2022
DOI: 10.1111/nyas.14802
|View full text |Cite
|
Sign up to set email alerts
|

Exploring epigenomic mechanisms of neural tube defects using multi‐omics methods and data

Abstract: Neural tube defects (NTDs) are a heterogeneous set of malformations attributed to disruption in normal neural tube closure during early embryogenesis. An in-depth understanding of NTD etiology and mechanisms remains elusive, however. Among the proposed mechanisms, epigenetic changes are thought to play an important role in the formation of NTDs. Epigenomics covers a wide spectrum of genomic DNA sequence modifications that can be investigated via high-throughput techniques.Recent advances in epigenomic technolo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 108 publications
0
1
0
Order By: Relevance
“…Moreover, investigators will need to integrate genetic data with information on epigenetic, environmental, and nutritional factors to obtain a more comprehensive understanding of the causes of individual NTDs (118). Advances in whole-genome sequencing, exome-whole sequencing, and next-generation sequencing may help researchers in beginning to comprehend the genetic and epigenetic basis of NTDs in humans (119,120). The use of proteomics and other "omics" technology can propel the identification of novel biomarkers and molecular networks implicated in NTDs, which is an indispensable step in the improvement of patient management (121,122).…”
Section: Future Perspectivesmentioning
confidence: 99%
“…Moreover, investigators will need to integrate genetic data with information on epigenetic, environmental, and nutritional factors to obtain a more comprehensive understanding of the causes of individual NTDs (118). Advances in whole-genome sequencing, exome-whole sequencing, and next-generation sequencing may help researchers in beginning to comprehend the genetic and epigenetic basis of NTDs in humans (119,120). The use of proteomics and other "omics" technology can propel the identification of novel biomarkers and molecular networks implicated in NTDs, which is an indispensable step in the improvement of patient management (121,122).…”
Section: Future Perspectivesmentioning
confidence: 99%